Literature DB >> 17470646

Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model.

Matthew E Griffith1, James E Moon, Erica N Johnson, Kyra P Clark, Joshua S Hawley, Duane R Hospenthal, Clinton K Murray.   

Abstract

Ciprofloxacin, gatifloxacin, and levofloxacin were evaluated for their abilities to prevent mortality in hamsters infected with a lethal inoculum of Leptospira interrogans serovar Portlandvere. Each agent produced a statistically significant survival advantage compared to no treatment and demonstrated survival similar to that seen with doxycycline therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470646      PMCID: PMC1913230          DOI: 10.1128/AAC.00240-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae.

Authors:  M Takahata; M Shimakura; R Hori; K Kizawa; Y Todo; S Minami; Y Watanabe; H Narita
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models.

Authors:  D Andes; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis.

Authors:  Johann Truccolo; Françoise Charavay; Fabrice Merien; Philippe Perolat
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 4.  Antimicrobial therapy of leptospirosis.

Authors:  Matthew E Griffith; Duane R Hospenthal; Clinton K Murray
Journal:  Curr Opin Infect Dis       Date:  2006-12       Impact factor: 4.915

5.  Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique.

Authors:  Clinton K Murray; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Broth microdilution susceptibility testing for Leptospira spp.

Authors:  Clinton K Murray; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.

Authors:  F Scaglione; J W Mouton; R Mattina; F Fraschini
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans.

Authors:  I Takashima; M Ngoma; N Hashimoto
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.

Authors:  S Arai; Y Gohara; A Akashi; K Kuwano; M Nishimoto; T Yano; K Oizumi; K Takeda; T Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy.

Authors:  J P Bédos; E Azoulay-Dupuis; P Moine; M Muffat-Joly; B Veber; J J Pocidalo; E Vallée
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  10 in total

1.  In vitro and in vivo activity of first generation cephalosporins against Leptospira.

Authors:  Brande M Harris; Peter J Blatz; Mary K Hinkle; Suzanne McCall; Miriam L Beckius; Katrin Mende; Janelle L Robertson; Matthew E Griffith; Clinton K Murray; Duane R Hospenthal
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

2.  In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.

Authors:  Antara Chakraborty; Satoshi Miyahara; Sharon Y A M Villanueva; Nina G Gloriani; Shin-Ichi Yoshida
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

3.  Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.

Authors:  Roseanne A Ressner; Matthew E Griffith; Miriam L Beckius; Guillermo Pimentel; R Scott Miller; Katrin Mende; Susan L Fraser; Renee L Galloway; Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

4.  Efficacy of a New Recrystallized Enrofloxacin Hydrochloride-Dihydrate against Leptospirosis in a Hamster Model.

Authors:  Alma Carrascosa; Lilia Gutierrez; Alejandro De la Peña; Irma E Candanosa; Graciela Tapia; Hector Sumano
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Comparative analyses of transport proteins encoded within the genomes of Leptospira species.

Authors:  Bora Buyuktimkin; Milton H Saier
Journal:  Microb Pathog       Date:  2016-06-11       Impact factor: 3.738

6.  Comparative genomic analyses of transport proteins encoded within the genomes of Leptospira species.

Authors:  Bora Buyuktimkin; Milton H Saier
Journal:  Microb Pathog       Date:  2015-08-03       Impact factor: 3.738

7.  2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention.

Authors:  J E Sykes; K Hartmann; K F Lunn; G E Moore; R A Stoddard; R E Goldstein
Journal:  J Vet Intern Med       Date:  2010-12-13       Impact factor: 3.333

8.  Doxycycline Attenuates Leptospira-Induced IL-1β by Suppressing NLRP3 Inflammasome Priming.

Authors:  Wenlong Zhang; Xufeng Xie; Dianjun Wu; Xuemin Jin; Runxia Liu; Xiaoyu Hu; Yunhe Fu; Zhuang Ding; Naisheng Zhang; Yongguo Cao
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

9.  Outpatient Clinical Trial in Dogs With Leptospirosis Treated With Enrofloxacin Hydrochloride-Dihydrate (ENRO-C).

Authors:  Lilia Gutierrez; Jesús Mendoza; Ana Bertha Rangel; Graciela Tapia; Maria Josefa Bernad; Hector Sumano
Journal:  Front Vet Sci       Date:  2019-10-15

10.  Pharmacokinetics of enrofloxacin HCl-2H2O (Enro-C) in dogs and pharmacokinetic/pharmacodynamic Monte Carlo simulations against Leptospira spp.

Authors:  Hector Sumano; Luis Ocampo; Graciela Tapia; Corazon de Jesus Mendoza; Lilia Gutierrez
Journal:  J Vet Sci       Date:  2018-09-30       Impact factor: 1.672

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.